Subscribe to our Newsletters !!

    Cardiovascular Disease

    Asthma doesn’t seem to expand the danger of contracting COVID-19, shows study

    Asthma doesn’t seem to increase the risk for an individual contracting COVID-19 or influence its own seriousness, as shown by a group of Rutgers research workers. “However, individuals with allergies –even those with diminished lung function that are being treated to control asthmatic inflammation–appear like no worse influenced by SARS-CoV-2 compared to the usual non-asthmatic

    CBD could lessen lung harm brought about by COVID-19

    One way CBD appears to reduce the”cytokine storm” that damages the lungs and kills many individuals with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is proven to reduce inflammation and whose levels are dramatically reduced in the face of this storm. Dental College of Georgia and Medical

    Polypill in addition to headache medicine and polypill alone reduced cardiovascular sickness hazard

    A single, daily pill combining blood pressure and cholesterol medications, as well as the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to late-breaking study presented today in a late-breaking clinical trial presentation at the American Heart Association’s Scientific Sessions 2020. The virtual conference,

    Smoking traditional cigarettes alongside e-cigarettes causes harmful wellbeing impacts

    Smoking traditional cigarettes in addition to using e-cigarettes leads to harmful health effects like smoking cigarettes exclusively, according to new research published today in the American Heart Association’s flagship journal Circulation. Smoking, a well-known link to cardiovascular disease and death, seems to be on the decline. While using e-cigarettes, known as vaping, is increasingly popular,

    Sulforaphane draws out life expectancy and healthspan of C. elegans through insulin/IGF-1 flagging

    Aging-US released”Sulforaphane boosts C. elegans longevity and healthspan through DAF- 16/DAF-2 insulin/IGF-1 signaling” which reported that the broccoli-derived isothiocyanate sulforaphane inhibits inflammation, oxidative stress and cancer, but its impact on healthspan and longevity are unclear. The writers used the C. elegans nematode version and fed the wildtype and 9 mutant strains ±sulforaphane. Sulforaphane increased the

    Researchers create shape memory polymer to comprehend the advancement of coronary illness

    Cardiovascular disease is still the number one cause of death globally. Unfortunately, the heart cannot regenerate new tissue, because the cardiomyocytes, or heart muscle cells, don’t divide after birth. In their paper, published in APL Bioengineering by AIP Publishing, Syracuse researchers developed a shape memory polymer to grow cardiomyocytes. Raising the substance’s temperature from 30

    FDA supports new medication for therapy of adults with chronic kidney infection

    Today, the U.S. Food and Drug Administration accepted Farxiga (dapagliflozin) oral tablets to decrease the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Chronic kidney disease occurs when the kidneys are damaged and can’t filter blood